LNSR Q2 2024 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$13M+5.2% YoY

Gross Profit

$7M52.1% margin

Operating Income

-$2M-12.3% margin

Net Income

-$9M-71.6% margin

EPS (Diluted)

$-0.79

QoQ Revenue Growth

+19.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$683,000

Balance Sheet

Total Assets

$61M

Total Liabilities

$24M

Stockholders' Equity

$37M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$12M	+5.2%
Gross Profit	$7M	$7M	-2.7%
Operating Income	-$2M	-$3M	+45.9%
Net Income	-$9M	-$9M	-3.3%

Revenue Segments

Product

$10M89%

Service

$1M11%

Geographic Segments

UNITED STATES

$8M72%

Europe

$2M16%

Asia Excluding South Korea

$988,0009%

KOREA, REPUBLIC OF

$304,0003%

Other Geographical Region

$44,0000%